Nice, France

Guillaume Robert

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2014-2015

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Guillaume Robert

Introduction

Guillaume Robert is a notable inventor based in Nice, France, recognized for his significant contributions to the field of pharmaceuticals. With a total of three patents to his name, he has focused on developing innovative therapeutic solutions, particularly in the treatment of cancer.

Latest Patents

Robert's latest patents include groundbreaking work on Acadesine derivatives. These patents describe products and compositions that utilize Acadesine derivatives as a drug, specifically targeting the treatment of cancer, including chronic myeloid leukemia. His inventions detail methods for synthesizing these derivatives and their use in pharmaceutical compositions, which may include a combination of active ingredients for effective cancer treatment. Additionally, he has explored the use of Simalikalactone E as an anticancer agent, aimed at preventing and treating various cancers.

Career Highlights

Throughout his career, Guillaume Robert has been associated with prestigious institutions such as Université Nice Sophia Antipolis and the Institut National de la Santé et de la Recherche Médicale. His work has significantly advanced the understanding and treatment of cancer, showcasing his dedication to medical research and innovation.

Collaborations

Robert has collaborated with esteemed colleagues, including Patrick Auberger and Rachid Benhida, further enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Guillaume Robert's innovative work in the pharmaceutical field, particularly in cancer treatment, highlights his role as a leading inventor. His patents and collaborations reflect a commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…